Pfizer Neurontin Is Second Agent For Postherpetic Neuralgia
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Pfizer’s Neurontin is the second drug cleared for treatment of postherpetic neuralgia (PHN), following FDA approval of the new indication May 24.